Stenotrophomonas maltophilia in Hemodialysis: An Opportunistic Pathogen or a Malevolent Foe.

Catheter-related bloodstream infections (CRBSIs) add to the morbidity and mortality of hemodialysis patients. is an extremely resistant, gram-negative, non-lactose-fermenting nosocomial bacterium that contributes significantly to mortality and morbidity. This bacterium is predominantly associated with community-acquired pneumonia, bacteremia, eye afflictions, biliary sepsis, urinary tract infection, skin and soft tissue infection, and very rarely chronic enteritis with colonic ulcers.

An abysmal conundrum associated with a misplaced dialysis catheter.

A 25-year-old female patient with chronic glomerulonephritis, initiated on haemodialysis presented with high-grade fever, a dysfunctional catheter, low oxygen saturation and unstable blood pressure. Upon evaluation, the patient was febrile with elevated white blood cell counts. She was intubated, started on inotropes and transferred to the intensive care unit.

A rare presentation of isolated candidal hepatic abscess in a maintenance hemodialysis patient.

A 61-year-old female with diabetes and stage 5 chronic kidney disease on hemodialysis since 3 years via left brachiocephalic arteriovenous fistula presented with uncontrolled sugars, weight loss, and dysphagia. On evaluation, she was found to have an oral thrush with leucocytosis. Initial blood and urine cultures were sterile, and ultrasonography revealed hypoechoic lesions in the left lobe of the liver.

An Analytical Study to Determine the Severity of COVID-19 Among Smokers.

Introduction In December of the year 2020, the SARS-CoV-2 virus was discovered in Wuhan, China. It extended to over 180 nations around the world. It can manifest in patients who are asymptomatic to those who are symptomatic, with symptoms ranging from anosmia to severe respiratory distress syndrome.

Prevalence and outcomes of D dimer elevation among the COVID-19 patients in tertiary care hospital, Salem.

Introduction: The Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which was initially reported in Wuhan and later spread to the rest of the world. The incidence of thrombotic events has been reported to be 16% in patients admitted for COVID-19 with an increase in the fibrinogen level and D-dimer level which was associated with mortality. D-Dimer was found to be elevated in severely ill patients admitted in the intensive care unit (ICU) and the dead patients.